Mandate

Vinge represents OMX in the creation of the world’s foremost securities exchange and technology company

May 29, 2007

Vinge is representing OMX in the recommended merger between OMX and NASDAQ that was announced today. This merger will be implemented through a public offer to purchase all the shares of OMX in return for cash and shares of NASDAQ. The offer is based on an evaluation of OMX at SEK 25.1 billion.

Vinge’s team includes Göran Nyström, Erik Sjöman, Maria-Pia Midenbäck, Dain Nevonen, Dan Hanqvist, Johan Karlsson, Kanja Berg, Christian Lindhé, Mattias Schömer and Maria Schultzberg.

Related

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025